IBDEI126 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17980,1,3,0)
 ;;=3^Syphilis,EArly Latent
 ;;^UTILITY(U,$J,358.3,17980,1,4,0)
 ;;=4^A51.5
 ;;^UTILITY(U,$J,358.3,17980,2)
 ;;=^266730
 ;;^UTILITY(U,$J,358.3,17981,0)
 ;;=A52.8^^76^859^89
 ;;^UTILITY(U,$J,358.3,17981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17981,1,3,0)
 ;;=3^Syphilis,Late Latent
 ;;^UTILITY(U,$J,358.3,17981,1,4,0)
 ;;=4^A52.8
 ;;^UTILITY(U,$J,358.3,17981,2)
 ;;=^266779
 ;;^UTILITY(U,$J,358.3,17982,0)
 ;;=A52.3^^76^859^90
 ;;^UTILITY(U,$J,358.3,17982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17982,1,3,0)
 ;;=3^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,17982,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,17982,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,17983,0)
 ;;=A52.9^^76^859^91
 ;;^UTILITY(U,$J,358.3,17983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17983,1,3,0)
 ;;=3^Syphilis,Tertiary
 ;;^UTILITY(U,$J,358.3,17983,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,17983,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,17984,0)
 ;;=A15.8^^76^859^93
 ;;^UTILITY(U,$J,358.3,17984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17984,1,3,0)
 ;;=3^Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,17984,1,4,0)
 ;;=4^A15.8
 ;;^UTILITY(U,$J,358.3,17984,2)
 ;;=^266093
 ;;^UTILITY(U,$J,358.3,17985,0)
 ;;=A15.0^^76^859^95
 ;;^UTILITY(U,$J,358.3,17985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17985,1,3,0)
 ;;=3^Tuberculosis,Pulmonary
 ;;^UTILITY(U,$J,358.3,17985,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,17985,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,17986,0)
 ;;=R76.11^^76^859^94
 ;;^UTILITY(U,$J,358.3,17986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17986,1,3,0)
 ;;=3^Tuberculosis,Latent
 ;;^UTILITY(U,$J,358.3,17986,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,17986,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,17987,0)
 ;;=N34.2^^76^859^97
 ;;^UTILITY(U,$J,358.3,17987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17987,1,3,0)
 ;;=3^Urethritis NEC
 ;;^UTILITY(U,$J,358.3,17987,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,17987,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,17988,0)
 ;;=N39.0^^76^859^96
 ;;^UTILITY(U,$J,358.3,17988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17988,1,3,0)
 ;;=3^UTI
 ;;^UTILITY(U,$J,358.3,17988,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,17988,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,17989,0)
 ;;=E55.9^^76^859^98
 ;;^UTILITY(U,$J,358.3,17989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17989,1,3,0)
 ;;=3^Vitamin D Deficiency
 ;;^UTILITY(U,$J,358.3,17989,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,17989,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,17990,0)
 ;;=R63.4^^76^859^99
 ;;^UTILITY(U,$J,358.3,17990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17990,1,3,0)
 ;;=3^Weight Loss
 ;;^UTILITY(U,$J,358.3,17990,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,17990,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,17991,0)
 ;;=T80.219A^^76^860^6
 ;;^UTILITY(U,$J,358.3,17991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17991,1,3,0)
 ;;=3^Infection d/t Central Venous Cath,Init Encntr
 ;;^UTILITY(U,$J,358.3,17991,1,4,0)
 ;;=4^T80.219A
 ;;^UTILITY(U,$J,358.3,17991,2)
 ;;=^5054359
 ;;^UTILITY(U,$J,358.3,17992,0)
 ;;=T80.211A^^76^860^1
 ;;^UTILITY(U,$J,358.3,17992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17992,1,3,0)
 ;;=3^Bloodstream Infection d/t Central Venous Catheter,Init Encntr
 ;;^UTILITY(U,$J,358.3,17992,1,4,0)
 ;;=4^T80.211A
 ;;^UTILITY(U,$J,358.3,17992,2)
 ;;=^5054350
 ;;^UTILITY(U,$J,358.3,17993,0)
 ;;=T80.212A^^76^860^14
 ;;^UTILITY(U,$J,358.3,17993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17993,1,3,0)
 ;;=3^Local Infection d/t Central Venous Catheter,Init Encntr
